Search Results 101-110 of 3409 for Solid
PRI-724 is thought to work by blocking the Wnt signaling pathway that cancer cells need to grow and spread(metastasize). Phase Ia: Patient cohorts with solid ...
The primary purpose of this study is to assess the safety and tolerability of RP-6306 in combination gemcitabine, in patients with eligible advanced solid ...
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
After completing residency, I returned to sunny Arizona as a Clinical Specialist Pharmacist in the Solid Organ Transplant Department at Mayo Clinic in Arizona.
Mayo Clinic researchers are seeking to overcome hurdles to advancing CAR-T cell therapy to solid tumors for thyroid cancer.
... solid tumors harboring an NRG1 fusion. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
The purpose of this study is to evaluate the side effects and best dose of AFP464 for treating patients who have solid tumors that are metastatic or ...
Curriculum for the PGY-2 Pharmacy Residency in Solid Organ Transplant at Mayo Clinic Hospital – Rochester, Minnesota.
... solid tumors. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
This phase I trial studies the side effects and best dose of ribociclib and gemcitabine hydrochloride in treating patients with solid tumors that have spread to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.